未登录.png)
分享.png)
收藏Major secondary outcomes in the multicentre noninferiority randomised trial IoN: Is ablative radioiodine necessary for low-risk differentiated thyroid cancer patients?多中心非劣效性随机试验IoN的主要次要结局: 对于低风险分化型甲状腺癌患者，消融性放射性碘是否必要？
Hackshaw, A.; Newbold, K.; Beasley, M.; Garcez, K.; Wadsley, J.; Johnson, S.; Stephenson, T.; Gaze, M. N.; Goodman, A.; Jeffries, S.; Wilkinson, D.; Macias, E.; Power, D.; Roques, T.; Speed, L.; Gerrard, G.; Forsyth, S.; Chang, E.; Farnell, K.; Mallick, U. K. 分享 收藏 分享 收藏 分享 收藏 Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (vol 32, pg 345, 2019)Pfeifer, H.; Cazzaniga, G.; van der Velden, V. H. J.; Cayuela, J. M.; Schafer, B.; Spinelli, O.; Akiki, S.; Avigad, S.; Bendit, I.; Borg, K.; Cave, H.; Elia, L.; Reshmi, S. C.; Gerrard, G.; Hayette, S.; Hermanson, M.; Juh, A.; Jurcek, T.; Chillon, M. C.; Homburg, C.; Martinelli, G.; Kairisto, V.; Lange, T.; Lion, T.; Mueller, M. C.; Pane, F.; Rai, L.; Damm-Welk, C.; Sacha, T.; Schnittger, S.; Touloumenidou, T.; Valerhaugen, H.; Vandenberghe, P.; Zuna, J.; Serve, H.; Herrmann, E.; Markovic, S.; van Dongen, J. J. M.; Ottmann, O. G. 分享 收藏 分享 收藏 Differentiated Thyroid Cancer in Children: A UK Multicentre Review and Review of the LiteratureLee, K. A.; Sharabiani, M. T. A.; Tumino, D.; Wadsley, J.; Gill, V; Gerrard, G.; Sindhu, R.; Gaze, M. N.; Moss, L.; Newbold, K. 分享 收藏 Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitorsNteliopoulos, Georgios; Bazeos, Alexandra; Claudiani, Simone; Gerrard, Gareth; Curry, Edward; Szydlo, Richard; Alikian, Mary; Foong, Hui En; Nikolakopoulou, Zacharoula; Loaiza, Sandra; Khorashad, Jamshid S.; Milojkovic, Dragana; Perrotti, Danilo; Gale, Robert Peter; Foroni, Letizia; Apperley, Jane F. 分享 收藏 分享 收藏 Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1Pfeifer, H.; Cazzaniga, G.; van der Velden, V. H. J.; Cayuele, J. M.; Schafer, B.; Spinelli, O.; Akiki, S.; Avigad, S.; Bendit, I; Borg, K.; Cave, H.; Elia, L.; Reshmi, S. C.; Gerrard, G.; Hayette, S.; Hermanson, M.; Juh, A.; Jurcek, T.; Chillon, M. C.; Homburg, C.; Martinelli, G.; Kairisto, V; Langen, T.; Lion, T.; Mueller, M. C.; Pane, F.; Rai, L.; Damm-Welk, C.; Sacha, T.; Schnittger, S.; Touloumenidou, T.; Valerhaugen, H.; Vandenberghe, P.; Zuna, J.; Server, H.; Herrmann, E.; Markovic, S.; van Dongen, J. J. M.; Ottmann, O. G. 分享 收藏 分享 收藏 分享 收藏 Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International ScaleCross, N. C. P.; White, H. E.; Ernst, T.; Welden, L.; Dietz, C.; Saglio, G.; Mahon, F-X; Wong, C. C.; Zheng, D.; Wong, S.; Wang, S-S; Akiki, S.; Albano, F.; Andrikovics, H.; Anwar, J.; Balatzenko, G.; Bendit, I.; Beveridge, J.; Boeckx, N.; Cerveira, N.; Cheng, S-M; Colomer, D.; Czurda, S.; Daraio, F.; Dulucq, S.; Eggen, L.; El Housni, H.; Gerrard, G.; Gniot, M.; Izzo, B.; Jacquin, D.; Janssen, J. J. W. M.; Jeromin, S.; Jurcek, T.; Kim, D-W; Machova-Polakova, K.; Martinez-Lopez, J.; McBean, M.; Mesanovic, S.; Mitterbauer-Hohendanner, G.; Mobtaker, H.; Mozziconacci, M-J; Pajic, T.; Pallisgaard, N.; Panagiotidis, P.; Press, R. D.; Qin, Y-Z; Radich, J.; Sacha, T.; Touloumenidou, T.; Waits, P.; Wilkinson, E.; Zadro, R.; Mueller, M. C.; Hochhaus, A.; Branford, S. 分享 收藏 Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic Myeloid Leukemia PatientsAlikian, Mary; Ellery, Peter; Forbes, Martin; Gerrard, Gareth; Kasperaviciute, Dalia; Sosinsky, Alona; Mueller, Michael; Whale, Alexandra S.; Milojkovic, Dragana; Apperley, Jane; Huggett, Jim F.; Foroni, Letizia; Reid, Alistair G. 分享 收藏 分享 收藏 PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phaseAlonso-Dominguez, Juan M.; Grinfeld, Jacob; Alikian, Mary; Marin, David; Reid, Alistair; Daghistani, Mustafa; Hedgley, Corinne; O'Brien, Stephen; Clark, Richard E.; Apperley, Jane; Foroni, Letizia; Gerrard, Gareth 分享 收藏 A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCRWhite, H.; Deprez, L.; Corbisier, P.; Hall, V.; Lin, F.; Mazoua, S.; Trapmann, S.; Aggerholm, A.; Andrikovics, H.; Akiki, S.; Barbany, G.; Boeckx, N.; Bench, A.; Catherwood, M.; Cayuela, J-M; Chudleigh, S.; Clench, T.; Colomer, D.; Daraio, F.; Dulucq, S.; Farrugia, J.; Fletcher, L.; Foroni, L.; Ganderton, R.; Gerrard, G.; Gineikiene, E.; Hayette, S.; El Housni, H.; Izzo, B.; Jansson, M.; Johnels, P.; Jurcek, T.; Kairisto, V.; Kizilors, A.; Kim, D-W; Lange, T.; Lion, T.; Polakova, K. M.; Martinelli, G.; McCarron, S.; Merle, P. A.; Milner, B.; Mitterbauer-Hohendanner, G.; Nagar, M.; Nickless, G.; Nomdedeu, J.; Nymoen, D. A.; Leibundgut, E. O.; Ozbek, U.; Pajic, T.; Pfeifer, H.; Preudhomme, C.; Raudsepp, K.; Romeo, G.; Sacha, T.; Talmaci, R.; Touloumenidou, T.; Van der Velden, V. H. J.; Waits, P.; Wang, L.; Wilkinson, E.; Wilson, G.; Wren, D.; Zadro, R.; Ziermann, J.; Zoi, K.; Mueller, M. C.; Hochhaus, A.; Schimmel, H.; Cross, N. C. P.; Emons, H. 分享 收藏 Fast-mode duplex qPCR for BCR-ABL1 molecular monitoring: Innovation, automation, and harmonizationGerrard, Gareth; Mudge, Katherine; Foskett, Pierre; Stevens, David; Alikian, Mary; White, Helen E.; Cross, Nicholas C. P.; Apperley, Jane; Foroni, Letizia 分享 收藏 BCR-ABL1 kinase domain mutations: Methodology and clinical evaluationAlikian, Mary; Gerrard, Gareth; Subramanian, Papagudi G.; Mudge, Katherine; Foskett, Pierre; Khorashad, Jamshid Sorouri; Lim, Ai Chiin; Marin, David; Milojkovic, Dragana; Reid, Alistair; Rezvani, Katy; Goldman, John; Apperley, Jane; Foroni, Letizia 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
